• Wejdan A Alhamdan, Thamer A Alsulaiman, Razan I Alsabti, Ola M Abdulmowla, Somayh E Elnaggar, and Yaser Alendijani.
• From the Department of Family Medicine and Polyclinics (Alhamdan, Alsulaiman, Alsabti, Alendijani), King Faisal Specialist Hospital and Research Center, and from the College of Medicine (Abdulmowla, Elnaggar), Al Faisal University, Riyadh, Kingdom of Saudi Arabia.
• Saudi Med J. 2023 Sep 1; 44 (9): 870874870-874.

ObjectivesTo assess the association between body mass index (BMI) and hemoglobin A1c (HbA1c) with serum prostate-specific antigen (PSA) level.MethodsA retrospective cohort study was carried out at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia, from January 2016 to December 2021. Data were collected from the medical records of patients who visited the family medicine clinics, including demographics, smoking status, BMI value, index PSA level, testosterone level, digital rectal exam findings, prostate biopsy status, fasting blood glucose (FBG), HbA1c, diabetes duration, chronic comorbidities (namely, hypertension, dyslipidemia, or chronic kidney disease), and medication history.ResultsThe mean PSA level was 1.89±4.02 ng/dL and mean HbA1c was 6.59±2.69%. Of the participants, 41.8% were overweight, 54.3% were non-diabetics, and 85.3% were nonsmokers. Only 11 (1.6%) participants had undergone a prostate biopsy after taking a PSA test. There was a positive correlation between PSA level and age, a negative correlation between PSA level and BMI, and no correlation between PSA level and HbA1c or FBG.ConclusionProstate-specific antigen levels were higher in older people and those with low BMIs. No correlations were found between PSA levels and HbA1c or FBG, even after adjusting for other variables. Moreover, no correlations were found between PSA levels and other comorbidities such as dyslipidemia, chronic kidney disease, and hypertension.Copyright: © Saudi Medical Journal.

12 keywords...

hide…